Klick Health Acquires Oxford PharmaGenesis to Strengthen Scientific and Commercial Expertise

By combining Oxford PharmaGenesis' expertise in medical affairs and market access with Klick Health's strengths in commercial strategy, medical communications, creative services, digital solutions, analytics, and experience design, the two companies aim to provide better support to life sciences organizations from scientific research to commercial success.

Read Also- DefenceTech Startup Six Robotics Raises €12 Mn in Seed Round

“We are beyond proud to join forces with Chris, Richard, and the entire team at Oxford PharmaGenesis as we focus on helping life sciences clients think holistically about how evidence, medical strategy, access considerations, and stakeholder engagement connect across the lifecycle with a scientific-to-commercial offering that unlocks the true potential of their innovations,” said Leerom Segal, Klick’s Co-Founder and Chairman. “From the moment we met, we were struck by all the commonalities we share and how rare it is for two organizations’ independence, work ethic, ethos, and histories to mirror each other quite like ours. We think it’s an important distinction that will set clients and team members up for success.”

Oxford PharmaGenesis CEO Chris Winchester said, “At Oxford PharmaGenesis, we are always looking for ways to bring the very best to our clients and create outstanding opportunities for our people. Joining Klick Health will ensure that we remain at the cutting edge of HealthScience communications but, more importantly, our shared values ensure a bright future together.”

COO Richard White added, “This is the story of two successful companies growing strongly by themselves, driven by a desire to give clients what they are going to need next, and realizing that we could achieve that better together. We are excited to continue building on our unrivaled heritage and unlocking new possibilities for our clients and our people.”

Klick’s Chief Medical Officer Holly Henry said, "I’m incredibly excited to help bring together two independent industry leaders united by a shared commitment to solving complex client challenges through scientific rigor, innovation, and excellence. By combining the strengths of Klick Health and Oxford PharmaGenesis, we are creating new opportunities to support our clients across every stage of the commercialization journey, from clinical development to loss of exclusivity, while delivering deeper expertise, broader capabilities, and even greater impact."

Oxford PharmaGenesis is a health science communications and consulting company. Founded in 1998, it is one of the largest independent companies in the healthcare communications industry.

The company has more than 500 employees working across North America, Europe, and Asia-Pacific, helping life sciences and healthcare organizations with scientific and medical communications.

Klick Health is one of the world's largest independent companies helping life sciences businesses develop, launch, and grow their products. It provides services such as marketing, advertising, media planning, medical communications, market access, technology, and analytics.

The company has a team of nearly 250 in-house medical experts with advanced degrees, along with specialists in data, analytics, and creative services. This combination helps life sciences companies bring their products to market and achieve better business results.